Abstract CT132: First in human trial of BAY2965501, a selective inhibitor of intra-cellular T cell checkpoint diacylglycerol kinase zeta (DGKζ), as monotherapy and combination with anti-PD-1
Ruth Plummer, Anna Minchom, Ramón Yarza, Hans Prenen et autres
gb, es, be, us, kr, jp, ch, cn, de (code pays fourni par la source)